Menu
GeneBe

rs121917904

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_000124.4(ERCC6):c.2047C>T(p.Arg683Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000421 in 1,613,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000043 ( 0 hom. )

Consequence

ERCC6
NM_000124.4 stop_gained

Scores

4
2
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 5.69
Variant links:
Genes affected
ERCC6 (HGNC:3438): (ERCC excision repair 6, chromatin remodeling factor) This gene encodes a DNA-binding protein that is important in transcription-coupled excision repair. The encoded protein has ATP-stimulated ATPase activity, interacts with several transcription and excision repair proteins, and may promote complex formation at DNA repair sites. Mutations in this gene are associated with Cockayne syndrome type B and cerebrooculofacioskeletal syndrome 1. Alternative splicing occurs between a splice site from exon 5 of this gene to the 3' splice site upstream of the open reading frame (ORF) of the adjacent gene, piggyback-derived-3 (GeneID:267004), which activates the alternative polyadenylation site downstream of the piggyback-derived-3 ORF. The resulting transcripts encode a fusion protein that shares sequence with the product of each individual gene. [provided by RefSeq, Mar 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 10-49482809-G-A is Pathogenic according to our data. Variant chr10-49482809-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1711.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ERCC6NM_000124.4 linkuse as main transcriptc.2047C>T p.Arg683Ter stop_gained 10/21 ENST00000355832.10
ERCC6NM_001346440.2 linkuse as main transcriptc.2047C>T p.Arg683Ter stop_gained 10/21

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ERCC6ENST00000355832.10 linkuse as main transcriptc.2047C>T p.Arg683Ter stop_gained 10/211 NM_000124.4 P1Q03468-1

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152074
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000239
AC:
6
AN:
251380
Hom.:
0
AF XY:
0.0000294
AC XY:
4
AN XY:
135854
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000431
AC:
63
AN:
1461866
Hom.:
0
Cov.:
31
AF XY:
0.0000413
AC XY:
30
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.0000549
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152074
Hom.:
0
Cov.:
31
AF XY:
0.0000269
AC XY:
2
AN XY:
74272
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000189
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cerebrooculofacioskeletal syndrome 1 Pathogenic:2
Pathogenic, no assertion criteria providedliterature onlyOMIMSep 01, 2008- -
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsNov 20, 2019This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
Cerebrooculofacioskeletal syndrome 1;C0242379:Lung cancer;C0265201:DE SANCTIS-CACCHIONE SYNDROME;C0751038:Cockayne syndrome type 2;C3151063:Age related macular degeneration 5;C3551173:UV-sensitive syndrome 1;C4310783:Premature ovarian failure 11 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 20, 2022- -
ERCC6-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJul 24, 2017The ERCC6 c.2047C>T (p.Arg683Ter) variant is a stop-gained variant predicted to result in premature termination of the protein. The p.Arg683Ter variant been reported in two studies in which it is found in two patients including one homozygote with cerebrooculofacioskeletal syndrome (CFSS) and one compound heterozygote with Cockayne syndrome (Laugel et al. 2008; Calmels et al. 2016). Control data are not available for the p.Arg683Ter variant which is reported at a frequency of 0.00005 in the European (non-Finnish) population of the Exome Aggregation Consortium. Western blot analysis demonstrated that the variant resulted in an absence of protein. Complementation assays in CFSS patient fibroblasts transfected with wild type ERCC6 demonstrated rescue of DNA repair deficiency (Laugel et al. 2008). Although the p.Arg683Ter variant is described in the literature in association with autosomal recessive inheritance, an increased risk for macular degeneration due to heterozygous variants may exist. Due to the potential impact of stop-gained variants and evidence from the literature, the p.Arg683Ter variant is classified as likely pathogenic for ERCC6-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeSep 26, 2023For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Arg683*) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). This variant is present in population databases (rs121917904, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with Cockayne syndrome (PMID: 18628313, 29572252). ClinVar contains an entry for this variant (Variation ID: 1711). -
DE SANCTIS-CACCHIONE SYNDROME Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingCounsylJan 13, 2017- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.51
D
BayesDel_noAF
Pathogenic
0.63
Cadd
Pathogenic
46
Dann
Uncertain
1.0
Eigen
Pathogenic
0.93
Eigen_PC
Pathogenic
0.81
FATHMM_MKL
Uncertain
0.96
D
MutationTaster
Benign
1.0
A;A
Vest4
0.96
GERP RS
4.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121917904; hg19: chr10-50690855; API